Tag: Revenue

Versant Q1 Sees Profit Slip On Revenue Dip, Corporate Costs

Versant Media has reported a decline in its first fiscal quarter profits, attributed to challenges in its TV

It’s Not Too Late to Buy AMD Stock as Revenue Surges

Advanced Micro Devices (NASDAQ: AMD) has been a standout performer this year, with its shares surging over 90%

Cloudflare says AI made 1,100 jobs obsolete, even as revenue hit a record high

On Thursday, Cloudflare announced it was joining a growing number of tech companies, such as Meta, Microsoft, and

Disney Q2 2026 Revenue Rises 7% in Earnings Beat, Streaming Income Up 88% to $582 Million

Disney has released its first earnings report under the leadership of CEO Josh D'Amaro, and the results are

First Watch revenue rises 17% to $331m in Q1 2026

First Watch Restaurant Group has reported a strong start to the year, with total revenue for the first

BlackRock Says Crypto Business To Generate $500 Million In Annual Revenue

BlackRock Predicts $500 Million in Annual Revenue from Crypto Business BlackRock Says Crypto Business To Generate $500 Million

Consumer Spending Drives European FIlm and TV Revenue to $165 Billion

In 2024, Europe's audiovisual industry achieved revenues of approximately €142 billion ($164.7 billion), primarily fueled by consumer spending.

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story

RTW Investments recently made a significant move by initiating a new stake in Apellis Pharmaceuticals (NASDAQ:APLS) during the

Wallbox (WBX) Reports €33.7M Q4 Revenue and 46% Adjusted EBITDA Improvement YoY

Wallbox (NYSE:WBX) has been identified as one of the best EV stocks to buy according to analysts. The

Cluely CEO Roy Lee admits to publicly lying about revenue numbers last year

The Truth Behind Cluely’s Alleged $7 Million in Annual Revenue Recently, co-founder and CEO of Cluely, Roy Lee,

Cadence Design Systems, Inc. (CDNS) Beats Q4 Revenue and EPS Expectations, Stifel Reaffirms Buy

Cadence Design Systems, Inc. (NASDAQ:CDNS) has been recognized as one of the top-performing S&P 500 stocks over the

Arcutis Biotherapeutics Spotlights ZORYVE Surge, 2025 Revenue Beat and Key FDA Milestones at TD Cowen

Arcutis Biotherapeutics, a leading clinical-stage biopharmaceutical company, recently showcased its impressive performance and outlined upcoming regulatory and pipeline